Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
Annals of Internal Medicine
|
April 15, 1994
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators
R C Becker, M Terrin, R Ross, et al.
Journal of the American College of Cardiology
|
April 1, 1995
Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study
R C Becker, A Charlesworth, R G Wilcox, et al.
Journal of Thrombosis and Thrombolysis
|
August 6, 1999
Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidence
E W Dickson, C P Reinhardt, F P Renzi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 21, 2008
A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor
M Y Chan, C P Rusconi, J H Alexander, et al.
Archives of Internal Medicine
|
March 17, 2001
Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction: a nationwide perspective
R C Becker, M Burns, N Every, et al.
Oligonucleotides
|
September 15, 2007
Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers
S Oney, S M Nimjee, J Layzer, et al.
The American Journal of Cardiology
|
July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
R C Becker, C P Cannon, E G Bovill, et al.
Journal of the American College of Cardiology
|
February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study
R C Becker, J S Hochman, C P Cannon, et al.
Journal of Thrombosis and Thrombolysis
|
September 29, 2001
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention
C Kimmelstiel, R Phang, A Rehman, et al.
Journal of Thrombosis and Thrombolysis
|
June 2, 2014
The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study
J P Vavalle, C P Rusconi, S Zelenkofske, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
Annals of Internal Medicine
|
April 15, 1994
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators
R C Becker, M Terrin, R Ross, et al.
Journal of the American College of Cardiology
|
April 1, 1995
Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study
R C Becker, A Charlesworth, R G Wilcox, et al.
Journal of Thrombosis and Thrombolysis
|
August 6, 1999
Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidence
E W Dickson, C P Reinhardt, F P Renzi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 21, 2008
A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor
M Y Chan, C P Rusconi, J H Alexander, et al.
Archives of Internal Medicine
|
March 17, 2001
Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction: a nationwide perspective
R C Becker, M Burns, N Every, et al.
Oligonucleotides
|
September 15, 2007
Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers
S Oney, S M Nimjee, J Layzer, et al.
The American Journal of Cardiology
|
July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
R C Becker, C P Cannon, E G Bovill, et al.
Journal of the American College of Cardiology
|
February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study
R C Becker, J S Hochman, C P Cannon, et al.
Journal of Thrombosis and Thrombolysis
|
September 29, 2001
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention
C Kimmelstiel, R Phang, A Rehman, et al.
Journal of Thrombosis and Thrombolysis
|
June 2, 2014
The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study
J P Vavalle, C P Rusconi, S Zelenkofske, et al.
Page
of 15